Phase 3 Hospital-Acquired Pneumonia Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL
Hospital-Acquired PneumoniaCommunity-acquired PneumoniaVentilator associated pneumonia+2 more
Jena University Hospital616 enrolled28 locationsNCT06134492
Recruiting
Phase 3
Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype
Hospital-Acquired Pneumonia
Nantes University Hospital450 enrolled26 locationsNCT06269900
Completed
Phase 3
A Phase 3, Randomized, Double-Blind, Parallel-Group, Multinational Trial of Intravenous Telavancin Versus Vancomycin for Treatment of Hospital-Acquired Pneumonia with a Focus on Patients with Infections Due to Methicillin-Resistant Staphylococcus aureus (ATTAIN I & ATTAIN II)
Hospital-Acquired Pneumonia
Theravance, Inc.750 enrolled1 locationACTRN12605000324617